Valuation: RaySearch Laboratories AB

Market Cap 7.19B 740M 649M 598M 560M 1.05B 69.85B 1.07B 2.78B 34.52B 2.78B 2.72B 120B P/E 2026 *
25.2x
P/E 2027 * 20.2x
Enterprise Value 7.1B 731M 641M 591M 553M 1.04B 68.97B 1.06B 2.75B 34.09B 2.75B 2.69B 118B EV / Sales 2026 *
5.04x
EV / Sales 2027 * 4.32x
Free-Float
80.09%
Yield 2026 *
1.91%
Yield 2027 * 2.47%
1 day+1.11%
1 week+1.35%
Current month-4.17%
1 month-4.73%
3 months+14.38%
6 months-7.14%
Current year-8.36%
1 week 201.1
Extreme 201.1
216.4
1 month 201.1
Extreme 201.1
227.6
Current year 167.6
Extreme 167.6
237
1 year 167.6
Extreme 167.6
369.5
3 years 56.5
Extreme 56.5
369.5
5 years 40.8
Extreme 40.8
369.5
10 years 40.8
Extreme 40.8
369.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+1.11%+1.35% - - 740M
+8.40%+11.78%-39.54%-15.04% 27.84B
+1.88%+9.31%-32.68%+189.21% 13.62B
-1.01%-1.08%-20.41%+57.72% 5.43B
+1.92%+5.98% - - 3.07B
+0.30%+13.66% - - 2.11B
+1.52%+2.77%+36.59%-41.96% 1.83B
-1.43%-7.17%-31.18% - 1.22B
-1.55%+29.80%+606.67%+863.64% 726M
-3.38%-9.25%-44.82%-62.97% 715M
Average +0.78%+6.09%+67.80%+165.10% 6.28B
Weighted average by Cap. +4.52%+8.93%-23.74%+59.37%

Financials

2026 *2027 *
Net sales 1.41B 145M 127M 117M 110M 206M 13.68B 210M 545M 6.76B 545M 533M 23.45B 1.6B 165M 145M 133M 125M 234M 15.57B 239M 620M 7.69B 620M 606M 26.68B
Net income 285M 29.34M 25.72M 23.71M 22.2M 41.63M 2.77B 42.49M 110M 1.37B 110M 108M 4.74B 355M 36.54M 32.04M 29.54M 27.65M 51.85M 3.45B 52.93M 137M 1.7B 137M 134M 5.91B
Net Debt -90M -9.26M -8.12M -7.49M -7.01M -13.15M -874M -13.42M -34.82M -432M -34.79M -34.03M -1.5B -265M -27.28M -23.92M -22.05M -20.64M -38.71M -2.57B -39.51M -103M -1.27B -102M -100M -4.41B
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Date Price Change Volume
26/06/26 SEK 211.00 +2.91% 15,017
25/06/26 SEK 205.04 +0.80% 365
24/06/26 SEK 203.40 -2.87% 3,188
23/06/26 SEK 209.41 +0.22% 11,825
22/06/26 SEK 208.95 +1.14% 616
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
209.80SEK
Average target price
330.00SEK
Spread / Average Target
+57.29%

Quarterly revenue - Rate of surprise